KKR & Co
KKR
89.67
-1.00
-1.10%
KKR & Co
US · KKR
#243 by market cap
Listed 1970
89.67
-1.00
-1.10%
Live - 5344 symbols - heartbeat 545s ago
· 2026-10-08 07:39
Pre-market
89.67
0.00%
After-hours
89.50
-0.19%
Overnight
89.52
-0.17%
- Market cap
- 80.49B
- P/E (TTM)i
- 28.65
- P/Bi
- 2.82
- EPSi
- 2.34
- Div yieldi
- 0.84%
- 52W posi
- 12%
Reader sentiment
Are you bullish or bearish on KKR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.79, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -11.04% YoY
Margins
- Gross margin
- 18.00%
- Operating margin
- 2.55%
- Net margin
- 11.65%
Key ratios & quality
- Altman Z-Scorei
- 0.79
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.40B | 4.22B | 4.23B | 16.23B | 5.70B | 14.50B | 21.88B | 19.46B |
| Gross profit | 1.02B | 2.10B | 2.08B | 6.90B | 2.01B | 4.86B | 3.84B | 3.46B |
| Selling & admin expenses | 715.11M | 791.54M | 780.64M | 1.94B | 2.35B | 2.72B | 2.92B | 2.97B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 306.36M | 1.31B | 1.30B | 4.95B | -345.58M | 2.14B | 926.20M | 490.20M |
| Pretax profit | 2.26B | 5.17B | 5.73B | 13.85B | -292.22M | 6.55B | 5.86B | 7.10B |
| Tax | -194.10M | 528.75M | 609.10M | 1.39B | 125.39M | 1.20B | 954.40M | 953.75M |
| Net profit | 2.45B | 4.64B | 5.12B | 12.45B | -417.61M | 5.36B | 4.91B | 6.15B |
| Basic EPS | 2 | 4 | 3 | 8 | -1 | 4 | 3 | 3 |
| Diluted EPS | 2.06 | 3.54 | 3.37 | 7.42 | -0.79 | 4.09 | 3.28 | 2.34 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.11B | 5.09B | 5.53B | 5.74B | 4.32B | 5.73B |
| Gross profit | -84.67M | 1.05B | 1.35B | 1.14B | 1.18B | 1.07B |
| Selling & admin expenses | 334.80M | 358.64M | 834.90M | 784.05M | 419.57M | 489.71M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -706.69M | 327.27M | 512.72M | 356.90M | 456.47M | 325.71M |
| Pretax profit | 771.07M | 1.53B | 2.20B | 2.60B | 462.89M | 1.37B |
| Tax | 86.57M | 174.30M | 359.74M | 333.14M | 185.39M | 246.11M |
| Net profit | 684.50M | 1.35B | 1.84B | 2.27B | 277.51M | 1.13B |
| Basic EPS | 0 | 1 | 1 | 1 | 0 | 1 |
| Diluted EPS | -0.22 | 0.50 | 0.90 | 1.16 | 0.38 | 0.70 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.16B | 4.39B | 9.03B | 39.66B | 43.65B | 191.49B | 218.75B | 243.38B |
| Cash & ST investments | 2.45B | 3.16B | 6.51B | 10.09B | 12.82B | 108.57B | 112.56B | 132.71B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 50.74B | 60.90B | 79.81B | 264.29B | 275.35B | 317.29B | 360.10B | 410.14B |
| Total current liabilities | 2.11B | 2.60B | 3.49B | 30.83B | 28.88B | 40.63B | 53.07B | 58.25B |
| Short-term debt | -- | -- | -- | -- | 400.00M | 200.00M | -- | -- |
| Long-term debt | 22.34B | 27.01B | 33.42B | 38.88B | 43.53B | 48.63B | 49.91B | 53.60B |
| Total liabilities | 25,360,766,000.00 | 30,396,945,000.00 | 39,006,586,000.00 | 206,146,220,000.00 | 219,975,946,000.00 | 258,915,282,000.00 | 298,114,719,000.00 | 328,512,161,000.00 |
| Total equity | 25.38B | 30.50B | 40.80B | 58.14B | 55.37B | 58.38B | 61.98B | 81.63B |
| Retained earnings | 91.95M | 1.79B | 3.44B | 7.67B | 6.70B | 9.82B | 12.28B | 13.88B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 225.20B | 148.24B | 241.26B | 243.38B | 244.38B | 242.95B |
| Cash & ST investments | 118.61B | 41.19B | 134.09B | 132.71B | 131.66B | 134.95B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 372.37B | 380.87B | 398.48B | 410.14B | 412.08B | 414.46B |
| Total current liabilities | 54.83B | 54.88B | 57.39B | 58.25B | 62.38B | 63.85B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 49.89B | 51.58B | 53.50B | 53.60B | 53.70B | 53.98B |
| Total liabilities | 303,415,987,000.00 | 309,899,128,000.00 | 323,078,973,000.00 | 328,512,161,000.00 | 331,278,266,000.00 | 334,012,983,000.00 |
| Total equity | 68.96B | 70.97B | 75.40B | 81.63B | 80.81B | 80.45B |
| Retained earnings | 11.94B | 12.25B | 12.94B | 13.88B | 14.08B | 14.57B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -7.61B | -5.68B | -5.95B | -7.18B | -5.28B | -1.49B | 6.65B | 477.76M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | -7.71B | -5.89B | -6.11B | -7.28B | -5.36B | -1.60B | 6.51B | 317.00M |
| Dividends paid | -355.71M | -304.85M | -353.88M | -419.63M | -513.34M | -615.03M | -612.07M | -768.54M |
| Stock buybacks / issuance | -173.14M | -72.12M | -246.16M | -231.25M | -346.65M | -289.84M | 0 | -3.36M |
| Ending cash balance | 2.64B | 3.24B | 6.99B | 10.53B | 13.39B | 20.81B | 15.37B | 17.15B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.55B | 438.76M | 2.39B | -4.90B | 1.75B | 3.25B |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 2.53B | 371.40M | 2.35B | -4.93B | 1.72B | 3.20B |
| Dividends paid | -155.44M | -202.54M | -205.25M | -205.31M | -205.24M | -215.54M |
| Stock buybacks / issuance | 0 | -3.36M | 0 | 0 | -191.24M | -41.98M |
| Ending cash balance | 18.39B | 18.06B | 22.89B | 17.15B | 19.49B | 21.20B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.34 | 21.32 | 17.32 | 31.92 | -5.50 | 18.65 | 13.23 | 8.61 |
| ROA %i | 2.28 | 3.53 | 2.76 | 2.65 | -0.34 | 1.24 | 0.91 | 0.58 |
| ROIC %i | 2.45 | 4.81 | 3.74 | 8.36 | -1.99 | 5.02 | 4.02 | 2.72 |
| 5-year avg ROE %i | 11.01 | 12.92 | 14.60 | 20.07 | 16.38 | 17.14 | 15.52 | 13.78 |
| EBIT margin %i | 130.76 | 147.17 | 158.28 | 91.03 | 10.12 | 66.33 | 42.36 | 52.95 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 30.08 | 1.65 |
| Current ratioi | 1.97 | 1.69 | 2.59 | 1.29 | 1.51 | 4.71 | 4.12 | 4.18 |
| Quick ratioi | 1.84 | 1.62 | 2.42 | 1.27 | 1.49 | 4.69 | 4.10 | 4.17 |
| Debt / assetsi | 44.03 | 44.56 | 42.12 | 14.87 | 16.01 | 15.57 | 14.11 | 13.30 |
| LT debt / equityi | 273.55 | 262.92 | 277.45 | 238.64 | 249.12 | 215.18 | 214.85 | 192.31 |
| Interest coveragei | 3.58 | 5.95 | 6.90 | 13.06 | 0.35 | 3.22 | 2.77 | 3.31 |
| Revenue CAGR (3Y) %i | 31.91 | 27.43 | 5.95 | 88.73 | 9.65 | 50.15 | 10.35 | 51.12 |
| Net income CAGR (3Y) %i | 32.30 | 86.46 | 25.28 | 61.14 | -- | 23.06 | -13.37 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.47 | 8.50 | 8.81 | 8.61 | 10.60 | 10.99 |
| ROA %i | 0.62 | 0.55 | 0.60 | 0.58 | 0.71 | 0.75 |
| ROIC %i | 2.84 | 2.56 | 2.82 | 2.72 | 3.50 | 3.72 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 56.24 | 54.65 | 55.54 | 52.95 | 48.47 | 46.23 |
| FCF / sales %i | 49.87 | 28.56 | 30.42 | 1.65 | -- | 11.11 |
| Current ratioi | 4.11 | 2.70 | 4.20 | 4.18 | 3.92 | 3.80 |
| Quick ratioi | 4.09 | 2.69 | 4.19 | 4.17 | 3.91 | 3.80 |
| Debt / assetsi | 13.64 | 13.78 | 13.66 | 13.30 | 13.26 | 13.26 |
| LT debt / equityi | 203.76 | 204.41 | 200.14 | 192.31 | 195.45 | 192.82 |
| Interest coveragei | 2.64 | 2.77 | 2.95 | 3.31 | 3.19 | 3.14 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Insurance is the largest reported line at 59.27% of revenue, across 3 reported segments.
- Asset Management follows at 49.61%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Insurance59.27%
Asset Management49.61%
Quote time 2026-10-08 07:39:21 · For reference only, not investment advice and not tailored to your situation.